Inmune Bio (INMB) Operating Leases (2019 - 2025)
Historic Operating Leases for Inmune Bio (INMB) over the last 7 years, with Q3 2025 value amounting to $623000.0.
- Inmune Bio's Operating Leases rose 11936.62% to $623000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $623000.0, marking a year-over-year increase of 11936.62%. This contributed to the annual value of $244000.0 for FY2024, which is 3853.9% down from last year.
- As of Q3 2025, Inmune Bio's Operating Leases stood at $623000.0, which was up 11936.62% from $451000.0 recorded in Q2 2025.
- Inmune Bio's 5-year Operating Leases high stood at $776000.0 for Q4 2021, and its period low was $95000.0 during Q3 2021.
- In the last 5 years, Inmune Bio's Operating Leases had a median value of $451000.0 in 2025 and averaged $450894.7.
- Its Operating Leases has fluctuated over the past 5 years, first soared by 69052.63% in 2022, then plummeted by 4701.49% in 2024.
- Inmune Bio's Operating Leases (Quarter) stood at $776000.0 in 2021, then dropped by 21.01% to $613000.0 in 2022, then crashed by 35.24% to $397000.0 in 2023, then tumbled by 38.54% to $244000.0 in 2024, then skyrocketed by 155.33% to $623000.0 in 2025.
- Its Operating Leases was $623000.0 in Q3 2025, compared to $451000.0 in Q2 2025 and $201000.0 in Q1 2025.